BIOANALYTICS

CRS‘ wide range of analytical capabilities

CRS collaborates with several well-established bioanalytical laboratories, providing solutions for the entire drug development process, whether small or large molecules are involved.

To this end, CRS offers a wide range of analytical capabilities. These include, among others, the characterization of New Molecular Entities (NME), the study of metabolism and metabolites, standard safety profiles formation, and biomarker research.

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board

LET’S TALK SCIENCE

+49 621 150 45 – 0

Martin Mulder

Senior Vice President Corporate & Business Development

LET’S TALK BUSINESS

+49 621 150 45 – 0

BACK TO OVERVIEW

CRO Leadership Awards 2019

CRS is proud to be recognised again by pharma companies worldwide as a leading CRO with regard to: capabilities, compatibility, quality and reliability.

European Biotechnology Guide

Find CRS’s company profile in the European Biotechnology Science Industry Guide, volume 9 2019.

EcoVadis – CSR Rating

Based on the CSR rating by EcoVadis in 2022 CRS has been granted Silver Recognition Level.